newsfilter
← Latest News
GlobeNewswire·

Ascendis to Share Latest Advances in Hypoparathyroidism and Achondroplasia Programs at ASBMR 2026

COPENHAGEN, Denmark, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (NASDAQ:ASND) today announced that the latest advances in its hypoparathyroidism and achondroplasia programs will be showcased during ASBMR